Bi2SiO5半导体光催化剂

Bi基半导体光催化剂具备独特的电子能带结构、可调节与可拓展的光谱响应范围、低毒及组成元素供给丰富等优点,使其成为高效、可实用型光催化剂的重要候选者。而Bi基非金属氧酸盐作为新型半导体光催化剂,其非金属氧酸根的表面修饰作用及高结晶性使其呈现出更加独特的光催化活性。本文简要介绍了Bi基半导体光催化剂的结构特性及近几年的研究进展,重点综述了Bi基非金属氧酸盐的一员--Bi₂SiO₅及其制备、异质结的构建和电子能带结构的研究进展,并对其今后的研究与应用方向作了进一步的展望。     

超高效液相色谱-四极杆-飞行时间质谱法定性筛查保健食品中西地那非及其相关功效类非法添加化合物

建立了超高效液相色谱-四极杆-飞行时间质谱（UPLC-Q-TOF-MS）定性筛查102种西地那非及其相关功效化合物的方法。甲醇超声提取样品;采用Agilent Poroshell 120 SB-C18色谱柱（75 mm×3.0 mm,2.7 μm）,以0.1%（v/v）甲酸水溶液-乙腈为流动相梯度洗脱,流速0.4 mL/min;采用电喷雾离子（ESI）源,Q-TOF-MS作检测器,正离子模式检测;与对照品保留时间、母离子及碎片离子精确相对分子质量、元素组成比对,准确定性。西地那非等100种化合物在10种基质中的检出限为0.1~50 mg/kg或0.1~50 mg/L。并分类归纳了文中涉及的98种磷酸二酯酶5抑制剂质谱碎片裂解规律,为可疑物的识别和鉴定提供参考。该方法已应用于实际样品的测定,检出19种化合物,有效打击了非法添加行为。     

Fe/MnO-ZnZSM-5双功能催化剂上合成气直接转化为芳烃的反应

 探讨了Fe／MnO－ZnZSM－5（n（SiO2）／n（Al2O3）＝50）双功能催化剂上合成气直接转化为芳烃的反应，考察了反应温度和Zn载量对CO转化率及芳烃选择性的影响．结果表明，Fe／MnO－ZnZSM－5具有良好的合成气芳构化性能，在V（CO）∶V（H2）∶V（Ar）＝3∶6∶1，SV＝1600h－1，p＝1．1MPa，T＝543K的条件下，CO转化率可达到98．1％，芳烃产物选择性可高达53．1％．催化剂经60h运转后，CO转化率仅降低0．5％，显示了良好的稳定性和应用前景．     

四苯基卟啉质子化结构变化的理论研究(Ⅱ)——五氟苯基及吡咯环上氟的取代基效应

卟啉的衍生物在DNA螺旋中的嵌入并堆积具有高选择性.为考察5,10,15,20-四(五氟苯基)卟啉(TF₅-PPH₂)和2,3,7,8,12,13,17,18-八氟-5,10,15,20-四(五氟苯基)卟啉(F₂₈TPPH₂)中F取代基对质子化卟啉结构的影响,在四苯基卟啉研究的基础上,用半经验的AM₁MO方法,并进行合理的对称性限制,计算了TF₅-PPH₂和F₂₈TPPH₂及其质子化二酸(TF₅-PPH₄²⁺)和(F₂₈TPPH₄²⁺)的几种可能的构型.结果表明,由于F取代基的影响,质子化过程中的结构、键电荷布居和前线分子轨道均有明显的变化,二者的质子化二酸与溶液质子的快速交换作用也都变得更加困难.     

吸热型碳氢燃料在银、镧改性ZSM-5分子筛上的裂解研究

为提高吸热型碳氢燃料的吸热能效，对HZSM－5分子筛进行了La^3 、Ag^ 离子交换改性，考察了吸热型碳氢燃料NNJ－150在HZSM－5及改性ZSM－5分子筛催化剂上的裂解情况。结果表明，La^3 、Ag^ 离子交换改性催化剂提高了NNJ－150的裂解气中低碳烯烃的选择性（500℃,81.63%)，并且改性催化剂和未改性催化剂的活性在35min内均未随进样时间下降，转化率也未降低（500℃,HZSM-5,64.62%;LaZSM-5,65.71%；AgZSM-5,68.75%)。实验结果表明，双金属离子改性可为今后研究的方向。     

化学位移估算研究ATP构象随溶液pH值的变化

利用Johnson和Bovey的理论和方法计算了不同扭曲角χ(O4′－C1′－N9－C4)的ATP(5′-三磷酸腺苷)分子中糖环质子H1′和H2′由于环流效应引起的化学位移.H1′的化学位移与扭曲角χ有较强的依赖关系,反映了ATP在溶液中细微的构象变化.将计算结果与实验结果比较,证明在本文讨论的pH值范围(1～10)内,Mg2＋加入后,ATP的扭曲角χ在230～360°范围内变化.随溶液的pH值减小,ATP分子的构象由trans 构象通过-gauche构象转变为cis构象. 从而证明在酸性条件下, ATP倾向于以cis构象存在,而在碱性条件下trans构象更为稳定,从另一方面支持了在酸性条件下N1参与配位而在碱性条件下N7参与配位的结论.在讨论中也考虑了由pH变化所引起的环流强度的变化.     

Development of a competitive ELISA for the quantification of F5 conjugate in HER2-targeted STEALTH immunoliposome doxorubicin in plasma samples

HER2 (human epidermal growth factor receptor 2, erbB2, or neu) is overexpressed by a large number of tumor types and has been identified as an important target for cancer therapy. F5 is a single-chain human antibody fragment that recognizes HER2 receptor and is covalently conjugated to PEGylated lipid to form F5 conjugate (F5CG) in the product HER2 targeted STEALTH immunoliposome doxorubicin. Here we described the method development of a competitive enzyme-linked immunosorbent assay (ELISA) for the determination of total concentration of F5 conjugate in plasma samples. The method involved the biotinylation of F5CG, detergent treatment of plasma sample to solubilize F5CG into monomeric form, and competitive ELISA for solubilized F5CG competitively binding to anti-F5CG antibody with biotinylated F5CG for the determination of total F5CG in plasma. The detection range of this method was from 0.2 ng/mL to 125 ng/mL for F5CG in plasma. The lower limit of quantification (LLOQ) was 0.2 ng/mL. This method was established and used for the measurement of F5CG concentration to provide information about F5CG circulation after the administration of immunoliposome in preclinical studies.      

Synthesis, complex-formation, and extracting ability of new derivatives of dithia-13(16)-crown-4(5) ethers

Various methods of synthesizing functional derivatives of dithia-13(16)-crown-4(5) ethers are proposed. Complex-formation of the obtained compounds with Ag⁺ and Pb²⁺ ions has been studied using ¹H NMR. A radiometric method was used to investigate the extracting ability of substituted dithia-13(16)-crown-4(5) ethers in relation to Ag⁺ and Cd²⁺ ions from aqueous solution in the presence of anions of various degree of hardness, with determination of the metal content. __________ Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 2, pp. 233–243, February, 2006.     

Improvement of basic performances of a nickel-metal hydride battery

To develop a sealed-type nickel-metal hydride battery for use in portable equipment or in electric vehicles, investigations were conducted on negative electrodes using AB₅-type hydrogen storage alloy and positive electrodes. For the cycle life performance of the battery, alkaline treatment of the alloy and the substitution of more than 50% to the alloy with Co were effective. For the positive electrode, zinc as a solid solution in the nickel positive electrode obviously prevented γ-NiOOH from being formed in the charging process of β-Ni(OH)₂ and suppressed the migration of the electrolyte solution in the separator to the active material of the positive electrode. Also, hydrophobic treatment of the surface of the alloy was effective to prevent the elevation of the battery internal pressure of the battery in high rate charge.     

5-苄基-4-叔丁基-2-芳氨基噻唑氢溴酸盐的合成、表征及抗肿瘤活性

以芳香胺和4,4-二甲基-1-芳基-2-溴戊-3-酮为原料, 设计合成了29种新的5-苄基-4-叔丁基-2-芳氨基噻唑氢溴酸盐化合物; 其结构经¹H NMR和元素分析等确证. 体外抗肿瘤活性测试结果表明, 化合物A4, A5, A12和A29对人非小细胞肺癌细胞A549的IC₅₀值分别为0.016, 0.019, 0.019和0.026 μmol/mL, 与阳性对照物紫杉醇(IC₅₀值为0.022 μmol/mL)相当; 化合物A5, A7, A13, A14和A19对肝癌细胞Bel7402的IC₅₀值分别为0.021, 0.021, 0.026, 0.014和0.029 μmol/mL, 与阳性对照物紫杉醇的IC₅₀值(0.030 μmol/mL)相近. 利用倒置显微镜和Hoechst33342-PI双染色法观察了细胞经化合物处理后的形态变化.